Inventor · disambiguated record
Manuel Vicente Salinas Martin
Also filed as: SALINAS MARTIN MANUEL VICENTE · SALINAS MARTÍN MANUEL VICENTE
1 granted patent·10 pending applications·0 citations·filing 2011–2021
14Inventor score
Top patents by PatentIndex Score
11 records- 0151US2020121689A1Use of non-peptide nk1 antagonists in a predetermined dose for the treatment of cancerSERVICIO ANDALUZ DE SALUD·Filed 2019·Application pending·0 cites
- 0241US10463670B2Use of non-peptide NK1 antagonists in a predetermined dose for the treatment of cancerSERVICIO ANDALUZ DE SALUD·Filed 2017·Granted Nov 5, 2019·0 cites·8 claims
- 0341US2020085845A1Use of agents that alter the peritumoral environment for the treatment of cancerSERVICIO ANDALUZ DE SALUD·Filed 2019·Application pending·0 cites
- 0440US2016317544A1Use of non-peptide nk1 antagonists in a predetermined dose for the treatment of cancerSERVICIO ANDALUZ DE SALUD·Filed 2014·Application pending·0 cites
- 0538US2019307694A1Neurokinin-1 receptor antagonist composition for treatment of diseases and conditions of the respiratory tractPLUS VITECH S L·Filed 2019·Application pending·0 cites
- 0634US2018071317A1Use of agents that alter the peritumoral environment for the treatment of cancerSERVICIO ANDALUZ DE SALUD·Filed 2017·Application pending·0 cites
- 0734US2024082273A1Neurokinin inhibitors such as aprepitant for treating non small cell lung carcinoma or breast cancer without mutationsPLUS VITECH S L·Filed 2021·Application pending·0 cites
- 0830US2015297613A1Use of agents that alter the peritumoral environment for the treatment of cancerSALINAS MARTIN MANUEL VICENTE·Filed 2012·Application pending·0 cites
- 0927US2017290774A1Neurokinin-1 receptor antagonist composition for treatment of diseases and conditions of the respiratory tractPLUS VITECH S L·Filed 2015·Application pending·0 cites
- 1019US2017052189A1Method for diagnosing and monitoring the presence of cancer in a human subjectSERVICIO ANDALUZ DE SALUD·Filed 2015·Application pending·0 cites
- 1115US2013280259A1Use of antibodies against nk1, nk2 and/or nk3 receptors in cancer treatmentSALINAS MARTIN MANUEL VICENTE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manuel Vicente Salinas Martin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →